Search - tctmd.com

Displaying 1 - 20 of 102

Sort: Relevancy | Date

News Conference News STS 2026

Industry Pays Far Less in Royalties, Consulting Fees to Female vs Male Surgeons

Yael L. Maxwell

February 09, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Conference News TCT 2025

What Makes MedTech Great—or Not—and Envisioning Its Future

Caitlin E. Cox

November 04, 2025

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

News Conference News EuroPCR 2025

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Yael L. Maxwell

May 21, 2025

News Conference News SCAI 2025

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

L.A. McKeown

May 02, 2025

News Conference News SCAI 2025

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

L.A. McKeown

May 02, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Daily News

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

Todd Neale

March 20, 2025

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

L.A. McKeown

March 10, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News PCR London Valves 2024

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Michael O'Riordan

November 26, 2024

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

Advertisement

Industry Pays Far Less in Royalties, Consulting Fees to Female vs Male Surgeons

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

What Makes MedTech Great—or Not—and Envisioning Its Future

FDA Expands Evolut Indications to Include Redo TAVI

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

CMS Agrees to Reimburse Transcatheter Tricuspid Valve Replacement

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Better 1-Year Echo and Clinical Outcomes With New Sapien Ultra Resilia

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content